glp 1 review article Discovery of GLP-1–Based Drugs for the Treatment of Obesity The Role of Glucagon-Like Peptide-1

B., Chicano-Glvez, E., Mora-Ortiz, M., Ohlsson, C., Poutanen, M., Pinilla, L., Gaytn, F., Douros, J

In view of the recent interest in GLP-1R agonism as a nonalcoholic fatty liver disease treatment, we evaluated liver histology after chronic treatment, showing greater steatosis resolution with exendin-phe1 (Fig

If something is missing or does not meet those thresholds, the request can be denied even with a valid prescription

Patients with autoimmune hypothyroidism who have appropriate indications such as type 2 diabetes or obesity may safely use these medications under medical supervision, provided they do not have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome

PMID: 31090818